Cooley LLP

Cooley is again the #1 law firm for venture-backed companies. According to the PitchBook Annual Global League Tables, Cooley is the top firm for representing companies in raising venture capital in the US and globally for the fifth year in a row. Other notable rankings include: #1 for venture-backed companies and investors in the US #1 for late-stage deals #1 for deals combined (company-side VC, M&A, PE, IPOs) 12 #1 rankings and the most #1 US regional rankings of any firm Congratulations to the team on these stellar results and thank you to our clients for driving our efforts! Read more: https://bit.ly/41IodAS

Cooley advised the Boston Celtics and the Grousbeck family – the majority stakeholders of Boston Basketball Partners, which owns the American professional basketball team – in connection with their agreement to sell the Celtics to an investor group led by William Chisholm. If approved, the new ownership group will buy a majority of the team in the summer of 2025 at an initial valuation of $6.1 billion. A major congratulations to the Boston Celtics and the Grousbeck family, and to the Cooley team led by Matt Hemington, Steven Tonsfeldt, David Silverman, Ga?l Hagan, Alanna (Allie) Anderson, Ryan Fitzgerald, Windfeld-Hansen Mark, Todd Gluth, Patrick Sharma, Megan Browdie and Rubin Waranch. ?? Read more here: https://bit.ly/4j122fp

Cooley’s Rita Sobral, Aaron Archer, Tamim Bazzi and Mike Lincoln teamed up with YPOG to host an insightful Venture Ecosystem Panel on the latest trends and insights related to artificial intelligence (AI), in addition to strategies and synergies between the German and US tech ecosystems, with a focus on exits. Thank you to our fantastic industry panelists – including Tobias Haar, (Aleph Alpha), Fabian Beringer (VidLab7), Alexander Langholz-Baikousis (Cherry Ventures) and Isabell Neubert (Detecon) – for sharing their insights on Germany to the US nexus. For more AI resources and to see the team’s full capabilities in this evolving space, visit our #CooleyAI page here: https://bit.ly/CooleyAI

Coming soon! An important conversation with Cooley cyber/data/privacy partner Kristen Mathews and brain-computer-interface participant J. Galen Buckwalter on all things mental privacy, including considerations for neurotech companies. Stay tuned for a recording of the discussion and, in the interim, read this Cooley alert exploring the legal and ethical frontiers of neural data: https://bit.ly/4irvlaz

A White House memorandum calls for changes to current US policy in furtherance of open investment and national security objectives. Once implemented, changes likely will expand restrictions in certain critical respects, while reducing them in others. ?? Read more from Cooley's Christopher Kimball, Annie Simpson Froehlich and Dillon Martinson here: https://bit.ly/3FxSHNq #CooleyREG

Cooley patent counseling and prosecution partner Mika Reiner Mayer and IP litigation partner Chad Shear will discuss how to avoid common IP diligence pitfalls and ensure your deals run smoothly during an upcoming Cooley Rx webinar on March 27. ?? Learn more and register here: https://bit.ly/4iKSdBT #BreakThroughWithCooley #CooleyRx

Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca for up to $1 billion on a cash- and debt-free basis. Congratulations to EsoBiotec and to the Cooley team led by Rama Padmanabhan, Rowook Park, Charity Williams, Simon Amies and Russell Anderson. ?? Read more here: https://bit.ly/4iy82w3 #BreakThroughWithCooley

Join #CooleyREG lawyers Emma Bichet, Athina Gaki, Susanne Sachsman Grooms, Jonas Koponen and Bartholom?us Regenhardt for a timely webinar that will provide insight into critical legislative initiatives introduced by the new European Commission, as well as an update on key pieces of European Union regulation that impact US companies. ?? Register for the event here: https://bit.ly/3Fud4v0

Rapid advancements in neurotechnology are challenging what many consider to be the last frontier of privacy, the sanctity of our inner thoughts, emotions and feelings. Cooley's Kristen Mathews and Tania (Soris) Butterfield explore the current state of the law on neural privacy, highlight emerging trends and suggest strategies for businesses looking to responsibly integrate neurotechnologies into their operations. Read more here: https://bit.ly/4i5udcY

Cooley advised Araris Biotech AG, a Swiss biotechnology company developing next-generation antibody-drug conjugates, on its definitive agreement to be acquired by Japan-based Taiho Pharmaceutical for up to $1.14 billion in cash. Congratulations to Araris Biotech and to the Cooley team led by Bill Roegge, Ken Krisko, Simon Amies, Rita Sobral and Stephanie Palmer. ?? Read more here: https://bit.ly/3DPe0JZ #BreakThroughWithCooley